Research & Development



  劉徹道︰“朕少年之時極為貪玩……只可惜當時局面不容我貪玩,動輒就有覆亡之禍,加上父皇並不是太喜歡我,如果不是粟姬昏招迭出,朕也難有今日。據兒生于深宮,長于婦人之手,加上沒有人可以爭奪他的儲位,這就讓他有些不思進取了。且容他松快兩年,兩年後,他也該跟朕展現一下他的才能了。”   阿嬌鄙夷的一笑,然後探出一根蔥白一般的手指點著桌子道︰“我長門宮的財源有的是,至今還有無數財源沒有開拓出來,開拓出來的財源才是財源,搶來的最多只能叫財寶。色一把-色一把伦理   劉徹嘆口氣對衛子夫道︰“天底下的聰明人都進了雲氏!”色一把看片网站   曹襄嘿嘿笑道︰“少年荒唐在所難免……”   卓姬皺眉道︰“你師傅連這樣的機密都跟你說?”色一下   “去未央宮不用翻越鴻台吧?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo